Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

NCT05060237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis
Keratosis, Actinic
Keratosis

Interventions

COMBINATION_PRODUCT: BF-200 ALA and red light LED lamp

Sponsor

Biofrontera Bioscience GmbH